Please login to the form below

Not currently logged in
Email:
Password:

Ex-Pfizer chief Kindler joins venture capital firm

Takes up role as venture partner at Lux Capital

Lux Capital Pfizer Jeff KindlerPfizer's former CEO and chairman Jeff Kindler has joined venture capital firm Lux Capital as a venture partner.

The New York-based firm said Kindler would help identify new healthcare investment opportunities and work with its portfolio of companies.

“With tremendous leadership experience in the healthcare industry, Jeff has an appreciation for the intersection of novel science, product development and commercial transactions,” said Robert Paull, managing partner at Lux Capital.

“As Lux continues to make new investments at the cutting edge of healthcare and as our life sciences portfolio matures, Jeff will prove to be an invaluable resource."

Kindler, whose current roles include acting as senior advisor to global investment company Paragon Pharmaceuticals, left Pfizer in 2010 after four years at the helm.

“I have great respect for the work Lux Capital is doing to build and back companies addressing some of healthcare's biggest challenges,” said Kindler. “It's a great group, and I look forward to being actively involved across the portfolio.”

Kindler has previously served as chairman of PhRMA (Pharmaceutical Researchers and Manufacturers of America) and, prior to joining Pfizer in 2002, he held senior legal roles at the General Electric Company and McDonald's Corporation

13th August 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics